首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Translocation mechanism of P-glycoprotein and conformational changes occurring at drug-binding site: Insights from multi-targeted molecular dynamics
【24h】

Translocation mechanism of P-glycoprotein and conformational changes occurring at drug-binding site: Insights from multi-targeted molecular dynamics

机译:P糖蛋白的移位机制和在药物结合位点发生的构象变化:多目标分子动力学的见解

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

P-glycoprotein (P-gp) is well known for multidrug resistance in drug therapy. Its over-expression results into the increased efflux of therapeutic agents rendering them inefficacious. A clear understanding of P-gp efflux mechanism and substrate/inhibitor interactions during the course of efflux cycle will be crucial for designing effective P-gp inhibitors, and therapeutic agents that are non-substrate to P-gp. In the present work, we have modeled P-gp in three different catalytic states. These models were utilized for elucidation of P-gp translocation mechanism using multi-targeted molecular dynamics (MTMD). The gradual changes occurring in P-gp structure from inward open to outward open conformation were sampled out. A detailed investigation of conformational changes occurring in trans-membrane domains (TMDs) during the course of catalytic cycle was carried out. Movements of each TM helices in response to pronounced twisting and translatory motion of NBDs were measured quantitatively. The role of intracellular coupling helices (ICHs) during the structural transition of P-gp was studied, and observed as vital links for structural transition. A close observation of displacements and conformational changes in the residues lining drug-binding pocket was also carried out. Further, we have analyzed the molecular interactions of P-gp substrates/inhibitors during the P-gp translocation to find out how stable binding interactions of a compound at drug-binding site(s) in open conformation, becomes highly destabilized in closed conformation. The study revealed striking differences between the molecular interactions of substrate and inhibitor; inhibitors showed a tendency to maintain stable binding interactions during the catalytic transition cycle.
机译:P-糖蛋白(P-gp)以药物治疗中的多药耐药性而闻名。其过表达导致治疗剂外排增加,使其无效。明确了解P-gp外排机制和外排循环过程中底物/抑制剂的相互作用,对于设计有效的P-gp抑制剂和非P-gp底物的治疗剂至关重要。在目前的工作中,我们已经模拟了三种不同催化状态下的P-gp。这些模型被用于阐明使用多目标分子动力学(MTMD)的P-gp易位机制。采样了从向内构象到向外构象的P-gp结构发生的逐渐变化。进行了详细的研究,在催化循环过程中跨膜域(TMDs)中发生的构象变化。定量测量了响应于NBD明显扭曲和平移运动的每个TM螺旋的运动。研究了细胞内偶联螺旋(ICH)在P-gp结构转变过程中的作用,并被观察为结构转变的重要环节。还仔细观察了药物结合袋内衬残留物的位移和构象变化。此外,我们已经分析了P-gp易位过程中P-gp底物/抑制剂的分子相互作用,以发现化合物在药物结合位点处呈开放构象的稳定结合相互作用在闭合构象下如何变得高度不稳定。研究发现底物和抑制剂的分子相互作用之间存在显着差异。抑制剂显示出在催化过渡循环期间保持稳定结合相互作用的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号